Results 41 to 50 of about 5,280 (85)

Avoidability of drug-induced liver injury (DILI) in an elderly hospital cohort with cases assessed for causality by the updated RUCAM score. [PDF]

BMC Geriatr, 2020
Danjuma MI, Almasri H, Alshokri S, Khir FK, Elmalik A, Battikh NG, Abdallah IMH, Elshafei M, Fatima H, Mohamed MFH, Maghoub Y, Hussain T, Kamal I, Anwer Z, Bidmos MA, Elzouki AN.   +15 more
europepmc   +1 more source

pDILI_v1: A Web-Based Machine Learning Tool for Predicting Drug-Induced Liver Injury (DILI) Integrating Chemical Space Analysis and Molecular Fingerprints. [PDF]

ACS Omega
Amin SA, Kar S, Piotto S.
europepmc   +1 more source

The evolution of strategies to minimise the risk of human drug-induced liver injury (DILI) in drug discovery and development. [PDF]

Arch Toxicol, 2020
Walker PA, Ryder S, Lavado A, Dilworth C, Riley RJ.   +4 more
europepmc   +1 more source

Regular Consumption of Green Tea as an Element of Diet Therapy in Drug-Induced Liver Injury (DILI). [PDF]

Nutrients
Winiarska-Mieczan A, Jachimowicz-Rogowska K, Kwiecień M, Borsuk-Stanulewicz M, Tomczyk-Warunek A, Stamirowska-Krzaczek E, Purwin C, Stryjecka M, Tomaszewska M.   +8 more
europepmc   +1 more source

Esbriet Pirfenidon medikamenteninduzierte Leberschdigung Drug-induced liver injury DILI [PDF]

Schweizerische Ärztezeitung, 2020
openaire   +2 more sources

Exploring Individual Variability in Drug-Induced Liver Injury (DILI) Responses through Metabolomic Analysis. [PDF]

Int J Mol Sci
Moreno-Torres M, Quintás G, Martínez-Sena T, Jover R, Castell JV.   +4 more
europepmc   +1 more source

A case report of a drug-induced liver injury (DILI) caused by multiple antidepressants with causality established by the updated Roussel Uclaf causality assessment method (RUCAM) and in vitro testing. [PDF]

Clin Case Rep, 2020
González-Muñoz M, Monserrat Villatoro J, Marín-Serrano E, Stewart S, Bardón Rivera B, Marín J, Martínez de Soto L, Seco Meseguer E, Ramírez E.   +8 more
europepmc   +1 more source

Drug-induced liver injury (DILI) ascribed to non-steroidal anti-inflammatory drugs (NSAIDs) in the USA-Update with genetic correlations. [PDF]

Liver Int
Bonkovsky HL, Ghabril M, Nicoletti P, Dellinger A, Fontana RJ, Barnhart H, Gu J, Daly AK, Aithal GP, Phillips EJ, Kleiner DE, US DILIN Investigators.   +11 more
europepmc   +1 more source

A computational study to identify Sesamol derivatives as NRF2 activator for protection against drug-induced liver injury (DILI). [PDF]

Mol Divers
Mili A, Birangal S, Nandakumar K, Lobo R.   +3 more
europepmc   +1 more source

Novel biomarkers for potential risk stratification of drug induced liver injury (DILI): A narrative perspective on current trends. [PDF]

Medicine (Baltimore), 2019
Danjuma MI, Sajid J, Fatima H, Elzouki AN.   +3 more
europepmc   +1 more source